SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 271 filers reported holding SEATTLE GENETICS INC in Q3 2017. The put-call ratio across all filers is 1.45 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $196,000 | -23.1% | 1,000 | -33.3% | 0.02% | -27.6% |
| Q2 2020 | $255,000 | +100.8% | 1,500 | +36.4% | 0.03% | +61.1% |
| Q1 2020 | $127,000 | +0.8% | 1,100 | 0.0% | 0.02% | +20.0% |
| Q4 2019 | $126,000 | +48.2% | 1,100 | +10.0% | 0.02% | +50.0% |
| Q3 2019 | $85,000 | +23.2% | 1,000 | 0.0% | 0.01% | +25.0% |
| Q2 2019 | $69,000 | -5.5% | 1,000 | 0.0% | 0.01% | -20.0% |
| Q1 2019 | $73,000 | +28.1% | 1,000 | 0.0% | 0.01% | +11.1% |
| Q4 2018 | $57,000 | -26.0% | 1,000 | 0.0% | 0.01% | 0.0% |
| Q3 2018 | $77,000 | -38.9% | 1,000 | -47.4% | 0.01% | -18.2% |
| Q2 2018 | $126,000 | +27.3% | 1,900 | 0.0% | 0.01% | +10.0% |
| Q1 2018 | $99,000 | -2.9% | 1,900 | 0.0% | 0.01% | 0.0% |
| Q4 2017 | $102,000 | -1.0% | 1,900 | 0.0% | 0.01% | +11.1% |
| Q3 2017 | $103,000 | +5.1% | 1,900 | 0.0% | 0.01% | 0.0% |
| Q2 2017 | $98,000 | -17.6% | 1,900 | 0.0% | 0.01% | -18.2% |
| Q1 2017 | $119,000 | – | 1,900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 51,049,760 | $3,738,884,000 | 23.93% |
| Lagoda Investment Management, L.P. | 76,873 | $5,630,000 | 7.16% |
| Matrix Capital Management Company, LP | 3,141,852 | $230,109,000 | 6.14% |
| DOMINI IMPACT INVESTMENTS LLC | 3,120 | $229,000 | 3.51% |
| Opus Point Partners Management, LLC | 17,832 | $1,306,000 | 1.77% |
| Capital International Sarl | 188,200 | $13,784,000 | 1.72% |
| EMORY UNIVERSITY | 33,368 | $2,444,000 | 1.72% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 60,900 | $4,460,000 | 1.65% |
| CAPITAL GUARDIAN TRUST CO | 1,358,254 | $99,415,000 | 1.32% |
| Rhenman & Partners Asset Management AB | 150,598 | $11,030,000 | 1.29% |